1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Genrix (Shanghai) Biopharmaceutical Co., Ltd.Phase 3 NCT06635798 Registry history of NCT06635798 on ClinicalTrials.gov (opens the registry)
Changed
| Phase 1 | 3 | |
| Phase 1/2 | 4 | |
| Phase 2 | 3 | |
| Phase 3 | 4 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07452198 | A Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in… | Multiple Myeloma | Recruiting | 2026-03-25 |
| NCT07154342 | A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis | Allergic Rhinitis, Seasonal | Recruiting | 2025-09-04 |
| NCT06516302 | A Study of GR1802 in Participants With Chronic Sinusitis With Nasal Polyps | Chronic Rhinosinusitis With Nasal Polyps | Active, Not Recruiting | 2026-03-03 |
| NCT07199257 | A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis. | Allergic Rhinitis, Seasonal | Not Yet Recruiting | 2025-09-30 |
| Phase 2 | ||||
| NCT06952075 | GR1803 Injection in Patients With RRMM | Multiple Myleoma | Recruiting | 2025-04-30 |
| NCT06566547 | GR1803 Injection in Patients With Relapsed/Refractory Multiple Myeloma | Multiple Myeloma | Active, Not Recruiting | 2026-05-27 |
| NCT06315426 | A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR). | Allergic Rhinitis | Active, Not Recruiting | 2025-04-25 |
| Phase 1/2 | ||||
| NCT07348055 | A Study of GR1803 in Systemic Lupus Erythematosus | Systemic Lupus Erthematosus | Recruiting | 2026-03-10 |
| NCT07647237 | A Clinical Trial of Multiple Doses of GR2301 Injection Combined With Phototherapy in… | Vitiligo | Not Yet Recruiting | 2026-06-15 |
| NCT07090954 | A Study of GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the… | Multiple Myeloma | Not Yet Recruiting | 2025-07-29 |
| NCT06015230 | Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in… | Lupus Erythematosus, Systemic | Active, Not Recruiting | 2024-09-25 |
| Phase 1 | ||||
| NCT07199270 | A Study to Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2303 in Healthy… | Health Adult Subjects | Recruiting | 2025-09-30 |
| NCT07647224 | A Clinical Trial of Multiple Doses of GR2301 Injection in Healthy Adult Trial… | Multiple Dose | Not Yet Recruiting | 2026-06-15 |
| NCT07190716 | A Study to Evaluate the Safety of GR2301 Injection in Healthy Volunteers. | Single Ascending Dose | Not Yet Recruiting | 2025-09-24 |
Multiple Myeloma (3) · Lupus (SLE) (2)